Zobrazeno 1 - 10
of 2 185
pro vyhledávání: '"antimuscarinic"'
Publikováno v:
Perspectives in Clinical Research, Vol 15, Iss 3, Pp 147-151 (2024)
Introduction: Overactive bladder (OAB) syndrome is a chronic disease characterized by urinary urgency with or without urge incontinence, frequency, and nocturia and antimuscarinic drugs such as solifenacin have been the mainstay of treatment. Mirabeg
Externí odkaz:
https://doaj.org/article/37acc67019c242f294fa5dc107ae478c
Autor:
Roger R. Dmochowski, Eric S. Rovner, Michael J. Kennelly, Diane K. Newman, Laleh Abedinzadeh, Daniel Snyder, Elizabeth Thomas, Cornelia Haag-Molkenteller, Matt T. Rosenberg
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Overactive bladder (OAB) is defined as urinary urgency accompanied by frequency and nocturia, with or without urge urinary incontinence (UUI). Vibegron, a selective β3-adrenergic receptor agonist approved in the US in December 20
Externí odkaz:
https://doaj.org/article/711a67b9010f4f20bebd247731097445
Autor:
Alison J. Huang, Louise C. Walter, Kristine Yaffe, Eric Vittinghoff, Erica Kornblith, Michael Schembri, Ann Chang, Leslee L. Subak
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-15 (2023)
Abstract Background Urgency-type urinary incontinence affects one in four older community-dwelling women and overlaps with other common aging-associated health syndromes such as cognitive impairment, physical mobility impairment, and depression. Obse
Externí odkaz:
https://doaj.org/article/29a2e45d97e04c88983668f466ca47ee
Publikováno v:
Toxicology Communications, Vol 7, Iss 1 (2023)
AbstractTreatment of antimuscarinic toxicity has become more difficult in the United States due to an ongoing national shortage of physostigmine. Rivastigmine has emerged as an alternative, off-label therapy due to its similar mechanism of action as
Externí odkaz:
https://doaj.org/article/32ded4a012294446adb8ad4ae02631d5
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background As people age, they accumulate several health conditions, requiring the use of multiple medications (polypharmacy) to treat them. One of the challenges with polypharmacy is the associated increase in anticholinergic exposure to ol
Externí odkaz:
https://doaj.org/article/d01f6514f10643d9ba0728cb521a1e39
Autor:
Parthasarathi Bhattacharyya, Dipanjan Saha, Moumita Chatterjee, Sayoni Sengupta, Debkanya Dey, Rajat Banerjee
Publikováno v:
Lung India, Vol 40, Iss 3, Pp 227-234 (2023)
Clinical Trial Registration: ECR/159/Inst/WB/2013/RR-20 Background: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agoni
Externí odkaz:
https://doaj.org/article/a68b42bd32724b69b4c76cd4a3e06ad5
Publikováno v:
Indian Journal of Anaesthesia, Vol 67, Iss 14, Pp 81-92 (2023)
Background and Aims: Catheter-related bladder discomfort (CRBD) is identified as a major concern after surgery as it can lead to increased morbidity and prolonged hospital stay. A suitable agent to prevent and treat postoperative CRBD is not yet esta
Externí odkaz:
https://doaj.org/article/cdb2594597114d0eb0e1f24148f6fd12
Publikováno v:
Drugs in Context, Vol 11, Pp 1-12 (2022)
Background: Few randomized controlled trials evaluate the long-term efficacy and safety of pharmacotherapy for overactive bladder (OAB). This network meta-analysis compares the long-term (52-week) efficacy and safety of vibegron, mirabegron and antic
Externí odkaz:
https://doaj.org/article/38234546bf3741fa8c2a5ff92b695a47
Publikováno v:
Medicina U.P.B., Vol 41, Iss 2, Pp 157-160 (2022)
La difenhidramina tiene efectos antihistamínico anti-H1 específico y antimuscarínico que pueden ocasionar un desenlace fatal según la dosis total ingerida. Se reporta un caso de intoxicación por difenhidramina tratado de forma exitosa con emulsi
Externí odkaz:
https://doaj.org/article/3d7506b74ec14ebdbc2a6b189a3ac873
Publikováno v:
Toxicology Communications, Vol 6, Iss 1, Pp 71-73 (2022)
AbstractGlycopyrronium is an antimuscarinic drug that is available in a moist towelette preparation for the treatment of primary axillary hyperhidrosis, which is characterized by excessive sweating on the palms, soles of feet, and axillary region. An
Externí odkaz:
https://doaj.org/article/88e6a6b21d2b4fafb43f766cdeeae31b